Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Kamada Ltd.

Market Cap 1.25B 125B 430M 372M 343M 320M 601M 40.92B 611M 4.06B 1.58B 19.9B 1.61B 1.58B 68.93B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 1.25B 125B 430M 372M 343M 320M 601M 40.92B 611M 4.06B 1.58B 19.9B 1.61B 1.58B 68.93B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.95x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 57 2015-06-30
Director of Finance/CFO 55 2017-12-30
Chief Operating Officer 53 2016-10-31
Director TitleAgeSince
Director/Board Member 75 1990-12-12
Chairman 77 2013-03-06
Chairman 55 2020-08-11
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-1.04% - - 430M
+0.11%-3.67%+17.30%-18.82% 62.28B
+1.44%+5.33%+68.08%+223.49% 60.59B
+0.70%+29.50%+29.50%+29.50% 39.55B
+0.26%+9.80%-55.40%-64.79% 36.8B
+0.05%+2.41%+51.20%-36.17% 29.53B
+0.65%+6.01%+56.79%+74.77% 21.68B
+0.54%+5.21%+82.49%-59.59% 19.8B
+4.80%-0.20%-5.33%+112.95% 16.96B
+0.18%-1.66%+49.80%+101.47% 16.16B
Average +0.82%+3.10%+32.71%+40.31% 33.71B
Weighted average by Cap. +0.80%+2.99%+31.06%+46.41%

Financials

2026 *2027 *
Net sales 585M 58.47B 201M 173M 160M 149M 280M 19.07B 285M 1.89B 736M 9.28B 753M 737M 32.12B 642M 64.19B 220M 190M 175M 164M 308M 20.93B 313M 2.08B 808M 10.18B 826M 808M 35.26B
Net income 72.01M 7.2B 24.7M 21.35M 19.67M 18.39M 34.51M 2.35B 35.07M 233M 90.69M 1.14B 92.68M 90.71M 3.96B 104M 10.36B 35.54M 30.73M 28.31M 26.47M 49.67M 3.38B 50.47M 335M 131M 1.64B 133M 131M 5.69B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
-
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!